Friday, May 8, 2009
Monday, April 13, 2009
NHAI to raise Rs 3000 crore in FY09-10
The National Highways Authority of India (NHAI) plans to raise Rs 3,000 crore in 2009-10 through tax-free bonds to fund the road projects.
According to sources, the bonds are expected to hit the market very soon.
It should be noted that the company has earlier raised Rs 1,700 crore in the last fiscal (2008-09) to strengthen the sector.
In addition, the highways regulator was reported in talks with the Asian Development Bank for a loan of $400 million (about Rs 2,000 crore) to fund road projects.
Last year the highways' regulator had planned to bid out 60 projects worth Rs 70,000 crore but, most of these projects failed to generate any response in the wake of the economic slowdown.
Posted by Blogger | Permalink | 0 comments
Sun Pharmaceutical gets USFDA nod for Oxycodone HCL tablets
Drug firm Sun Pharmaceutical Industries has informed that the US health regulator Food & Drug Administration (FDA) has finally granted its subsidiary an approval for its Abbreviated New Drug Application (ANDA) to market oxycodone hydrochloride tablets.
The drug is a generic version of Xanodyne Pharmaceuticals' Roxicodone tablet, which is used as a narcotic painkiller in the treatment of moderate to severe pain. The company said that it would launch the products in US market shortly, in the strength of 5mg, 15mg and 30mg.
According to reports, oxycodone tablets have annual sales of approximately US$160 million in the US.
Recently, Sun Pharmaceutical got U. S. Food & Drug Administration approval to make and sell generic versions of anticonvulsant topiramate tablets.
At 3:10 pm, the shares of company were trading at Rs 1148 on BSE, up by Rs 20.90 or 1.85%. The stock hit an intraday high of Rs 1163 and low of Rs 1127.10.
Posted by Blogger | Permalink | 0 comments
Subscribe to:
Posts (Atom)